首页 | 本学科首页   官方微博 | 高级检索  
     


DNA Methylation and Cancer Diagnosis
Authors:Yannick Delpu  Pierre Cordelier  William C. Cho  Jér?me Torrisani
Affiliation:1.Cancer Research Center of Toulouse Inserm UMR 1037, 31432 Toulouse cedex 4, France; E-Mails: (Y.D.); (P.C.);2.University de Toulouse III-Paul Sabatier, 118 Route de Narbonne, 31062 Toulouse cedex 9, France;3.Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China; E-Mail:
Abstract:DNA methylation is a major epigenetic modification that is strongly involved in the physiological control of genome expression. DNA methylation patterns are largely modified in cancer cells and can therefore be used to distinguish cancer cells from normal tissues. This review describes the main technologies available for the detection and the discovery of aberrantly methylated DNA patterns. It also presents the different sources of biological samples suitable for DNA methylation studies. We discuss the interest and perspectives on the use of DNA methylation measurements for cancer diagnosis through examples of methylated genes commonly documented in the literature. The discussion leads to our consideration for why DNA methylation is not commonly used in clinical practice through an examination of the main requirements that constitute a reliable biomarker. Finally, we describe the main DNA methylation inhibitors currently used in clinical trials and those that exhibit promising results.
Keywords:DNA methylation   biomarkers   cancer diagnosis   DNA methylation inhibitors   clinical trials
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号